Critical Care

official impact factor 4.60

Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?

Moritoki Egi, Rinaldo Bellomo* and Michael C Reade

Critical Care 2009, 13:302 doi:10.1186/cc7755

Accesses  

  • Last 30 days: 67 accesses
  • Last 365 days: 674 accesses
  • All time: 2455 accesses